文献
J-GLOBAL ID:201702264701883419
整理番号:17A1714755
必ずしもすべての免疫チェックポイント阻害剤は同等に創られている:癌臨床試験における免疫関連有害事象のメタ分析と系統的レビュー【Powered by NICT】
Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
著者 (7件):
El Osta B.
(Department of Hematology/Medical Oncology, Atlanta VA Medical Center, Decatur, GA 30033, United States)
,
El Osta B.
(Winship Cancer Institute of Emory University, Atlanta, GA 30322, United States)
,
Hu F.
(Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, United States)
,
Sadek R.
(Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, United States)
,
Chintalapally R.
(Department of Hematology/Oncology, Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, United States)
,
Tang S.-C.
(Department of Hematology/Oncology, Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, United States)
,
Tang S.-C.
(Tianjin Medical University Cancer Institute and Hospital, Tianjin, China)
資料名:
Critical Reviews in Oncology / Hematology
(Critical Reviews in Oncology / Hematology)
巻:
119
ページ:
1-12
発行年:
2017年
JST資料番号:
W3146A
ISSN:
1040-8428
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)